A Phase II Multi-cohort Clinical Study Evaluating The Efficacy and Safety of KN046 in Combination With Regorafenib for Metastatic Microsatellite-Stable Colorectal Cancer: a Phase II Multi-cohort Study
Latest Information Update: 30 Oct 2023
At a glance
- Drugs Erfonrilimab (Primary) ; Regorafenib (Primary)
- Indications Adenocarcinoma; Colorectal cancer
- Focus Therapeutic Use
Most Recent Events
- 26 Aug 2023 Status changed from not yet recruiting to recruiting.
- 17 Aug 2023 New trial record